SCHEMBL16201367

SCHEMBL16201367

CCCN(C)Cc1c[nH]nc1-c1cc(F)ccc1Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HTR1A P08908 2/20 0.33
HTR2B P41595 2/20 0.33
HTR2C P28335 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
HTR2A P28223 5/20 0.33
MEN1 O00255 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
PLA2G1B P04054 1/20 0.32
ATM Q13315 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
ATG4B Q9Y4P1 1/20 0.32
CARM1 Q86X55 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16201348 0.91 NISCH (0.36) ALDH1A1KDM4EHTR1ASLC6A2SLC6A4
SCHEMBL16201197 0.89 CARM1 (0.42) ALDH1A1KDM4ESLC6A2SLC6A4SLC6A3
SCHEMBL16201354 0.87 HTR2A (0.34) ALDH1A1KDM4EHTR1AHTR2BHTR2C
SCHEMBL16201411 0.87 ALDH1A1 (0.39) ALDH1A1KDM4ESLC6A2SLC6A4HTR2A
SCHEMBL16201356 0.85 ALDH1A1 (0.41) ALDH1A1KDM4EHTR2AMEN1GAA
SCHEMBL16201423 0.85 KDM4E (0.46) ALDH1A1KDM4EHTR2CSLC6A2SLC6A4
SCHEMBL16201413 0.84 NMT1 (0.40) ALDH1A1KDM4EHTR2AMEN1GAA
SCHEMBL16201395 0.83 HRH3 (0.34) HTR1AHTR2BHTR2CSLC6A4SLC6A3
SCHEMBL16201381 0.83 CRHR1 (0.41) KDM4EHTR1AHTR2BHTR2CMEN1
SCHEMBL16201401 0.82 ALDH1A1 (0.44) ALDH1A1KDM4EHTR2CHTR2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9776972-B2 Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof EPIZYME INC. (US) 2017-10-03 US disclosed
US-9346761-B2 Arginine methyltransferase inhibitors and uses thereof Epizyme, Inc. (US) 2016-05-24 US disclosed
US-20160137609-A1 PYRAZOLE DERIVATIVES AS ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2016-05-19 US disclosed
US-20140323537-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2014-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140323537-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF PRMT1, PRMT3, PRMT5 ALDH1A1 686/4885KDM4E 157/4885HTR1A 4078/4885
US-20160137609-A1 PYRAZOLE DERIVATIVES AS ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF PRMT1, PRMT3, PRMT5 ALDH1A1 895/4885KDM4E 288/4885HTR1A 4020/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.